About PRE-EMPT

The Prospective RandomizEd  Evaluation and Management of Premature aTherosclerosis (PRE-EMPT) Study is a clinical study sponsored by the National Heart, Lung, and Blood Institute (NHLBI).  The objective of the study is to optimize the identification of adults who have coronary atherosclerosis despite low short-term cardiovascular (CV) risk, and to test the effect of lipid-lowering and anti-inflammatory interventions on atherosclerosis compared with placebo, on the background of a mobile health lifestyle intervention.

This website contains materials for the study’s Data and Safety Monitoring Board. If you are not a DSMB member and are looking for more information about the PRE-EMPT study, please visit the study website at preemptstudy.org.  DSMB members, if you have any difficulties accessing the materials on this site, please email preempt_dcc@unc.edu